L’Oréal Group has agreed to acquire a majority stake in British skin care brand Medik8, further bolstering its Luxe division. The acquisition, subject to regulatory approvals, will see Inflexion, a European private equity firm, retain a minority stake. Medik8’s founder, Elliot Isaacs, will remain part of the brand’s continued leadership team.
